Mark For: ODXX™ trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 88639685 |
Mark Literal Elements | ODXX |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK. SERVICE MARK |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2020-05-05 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Margaret McHugh |
Attorney Docket Number | 1159893 |
Law Office Assigned | L20 |
Employee Name | CHOSID, ROBIN S |
2019-10-02 | Application Filed |
2019-11-19 | Location: TMEG LAW OFFICE 102 - EXAMINING ATTORNEY ASSIGNED |
2019-11-19 | Status: Live/Pending |
2019-11-19 | Transaction Date |
2020-03-10 | Published |
2020-05-05 | Location: INTENT TO USE SECTION |
2020-09-14 | Status: A first request for extension of time to file a Statement of Use has been granted. |
Party: | Genomic Health, Inc. |
Address | 301 Penobscot Drive Redwood City, CALIFORNIA UNITED STATES 94063 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
Drawing | JPEG | 2019-10-02 |
TEAS RF New Application | MULTI | 2019-10-02 |
XSearch Search Summary | XML | 2019-11-14 |
XSearch Search Summary | XML | 2019-11-18 |
Offc Action Outgoing | XML | 2019-11-19 |
Response to Office Action | APPLICATION/XML | 2020-01-23 |
Amendment and Mail Process Complete | MULTI | 2020-02-05 |
TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-02-07 |
Notice of Publication | XML | 2020-02-19 |
Notification Of Notice of Publication | XML | 2020-02-19 |
OG Publication Confirmation | APPLICATION/XML | 2020-03-10 |
Notice of Allowance | APPLICATION/XML | 2020-05-05 |
Change Address or Representation Form | XML | 2020-06-19 |
Extension of Time to File SOU | XML | 2020-09-14 |
ITU Extension Approval | XML | 2020-09-16 |
ITU Unit Action | APPLICATION/XML,IMAGE/JPEG | 2020-09-16 |
IC 001. US 001 005 006 010 026 046. G & S: Assays for testing tissue samples and bodily fluids for use in scientific research in the field of cancer detection, analysis and prognosis; diagnostic assays for testing tissue samples and bodily fluids for use in scientific research in the field of cancer detection, analysis and prognosis; clinical diagnostic reagents; reagents for scientific or medical research use, namely, reagents for use in preparation of RNA samples; kits consisting primarily of enzymes for scientific and research purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing; diagnostic kits comprised primarily of diagnostic reagents for clinical or medical laboratory use and diagnostic assays for testing tissue samples and bodily fluids for clinical or medical laboratory use in the field of cancer detection, analysis and prognosis; diagnostic kits comprised primarily of enzymes for scientific and research purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing
IC 005. US 006 018 044 046 051 052. G & S: Diagnostic kits comprised of medical diagnostic reagents and diagnostic assays for testing tissue samples and bodily fluids for use in cancer detection, analysis and prognosis; medical reagents; medical diagnostic reagents; kits for medical purposes consisting primarily of enzymes, nucleic acids, buffers, reagents and assays for use in disease testing and classification; diagnostic kits consisting primarily of enzymes for medical purposes, and also including nucleic acids, buffers, reagents and assays for use in disease testing and classification; medical diagnostic assays for testing of bodily fluids and tissue samples for use in disease detection and testing for medical and prognostic purposes; medical diagnostic reagents and assays for testing bodily fluids and tissue samples for use in disease testing and classification; enzyme preparations for medical purposes; biological preparations for the detection, diagnosis and monitoring of cancer for treatment purposes; preparations for detecting genetic predispositions for medical purposes; biological preparations for use in the diagnosis, analysis and prognosis of cancer, for treatment purposes; diagnostic agents, preparations and substances for medical purposes
IC 042. US 100 101. G & S: Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical testing services and information in the field of cancer research and disease classification
IC 044. US 100 101. G & S: Medical testing for diagnostic and prognostic purposes in the field of cancer and disease classification; providing medical information to medical professionals in the form of reports in the field of cancer and disease classification
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0011 | assays for testing tissue samples and bodily fluids for use in cancer detection, analysis and prognosis; diagnostic assays for testing tissue samples and bodily fluids for use in cancer detection, analysis and prognosis; clinical diagnostic reagents; reagents for scientific or medical research use, namely, reagents for use in preparation of RNA samples; kits consisting primarily of enzymes for scientific and research purposes, nucleic acids, buffers, reagents and assays for use in disease testing; diagnostic kits comprised primarily of diagnostic reagents for clinical or medical laboratory use and diagnostic assays for testing tissue samples and bodily fluids for use in cancer detection, analysis and prognosis; diagnostic kits comprised primarily of enzymes for scientific and research purposes, nucleic acids, buffers, reagents and assays for use in disease testing |
Description | Date | Proceeding Number |
---|---|---|
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-09-16 | |
TEAS EXTENSION RECEIVED | 2020-09-14 | |
EXTENSION 1 GRANTED | 2020-09-14 | 98765 |
EXTENSION 1 FILED | 2020-09-14 | 98765 |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-06-19 | |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-06-19 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-06-19 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-06-19 | |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-06-19 | 88888 |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-05-05 | |
PUBLISHED FOR OPPOSITION | 2020-03-10 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-03-10 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-02-19 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-02-06 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-02-04 | 70629 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-02-04 | 70629 |
ASSIGNED TO LIE | 2020-01-29 | 70629 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-01-23 | |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-11-19 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-11-19 | 77654 |
NON-FINAL ACTION E-MAILED | 2019-11-19 | 6325 |
ASSIGNED TO EXAMINER | 2019-11-11 | 77654 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-10-06 | |
NEW APPLICATION ENTERED IN TRAM | 2019-10-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.